Through activating antitumor immune cells and regulating the percentages of CD3+, CD4+, CD8+ T cells and CD19 B cells in tumor-bearing mice, APS have been found to be practical as a supplement for immune enhancement that can promote anaerobic metabolism of the TME and cell apoptosis [101]. The gene discussed is CD8A; the disease is neoplasm.